Home › Therapeutic areas › Immunology › Crohn's Disease
Crohn's Disease (5 companies)
Companies with an active program in Crohn's Disease.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| AGMB | Agomab Therapeutics | ImmunologyRespiratory Rare | 1 | Phase 2 | 4 |
| PALI | Palisade Bio | Immunology | 1 | Phase 2 | 3 |
| PTGX | Protagonist Therapeutics | DermatologyHematology+2 Rare | 1 | Approved | 14 |
| SYRE | Spyre Therapeutics | DermatologyImmunology Rare | 3 | Phase 2 | 12 |
| XNCR | Xencor | ImmunologyNeurology+1 Rare | 2 | Approved | 28 |
No companies match.